| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | docetaxel:tanespimycin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.073 | 0.03 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.03 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.079 | 0.03 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.03 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.03 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.077 | 0.03 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.03 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.03 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |